Healthcare -
Biotechnology - NASDAQ - US
$ 14.7
4.33 %
$ 1.67 B
Market Cap
-3.88
P/E
DYN - RESEARCH & DEVELOPMENT
Research & Development DYN - Dyne Therapeutics, Inc.
281 M
LAST VALUE
40.40%
2 YEAR CAGR
91.11%
5 YEAR CAGR
0.00%
10 YEAR CAGR